Wozencraft A O, Lloyd C M, Staines N A, Griffiths V J
Division of Biomolecular Sciences, King's College, London, United Kingdom.
Infect Immun. 1990 Jul;58(7):2156-64. doi: 10.1128/iai.58.7.2156-2164.1990.
We performed a series of studies to examine the sequential development of nephritis during murine malaria infections and to define the role of DNA-binding antibodies in the associated pathology. Serum levels of these antibodies were assessed throughout acute and chronic malaria infections. Increased levels of double-stranded DNA- and single-stranded DNA-binding antibodies were initially detected in mice infected with Plasmodium vinckei or Plasmodium yoelii nigeriensis during the middle stages of infection, and these levels were maintained until death. Infection with the more chronic organism Plasmodium berghei clone RC also resulted in increased single-stranded DNA-binding antibody titers, which fluctuated as the infection progressed. All three species caused kidney damage and dysfunction, as assessed by changes in morphology, blood urea nitrogen, and excreted albumin; this damage correlated with the extent of parasitemia and was observed before the levels of DNA-binding antibodies were detectably elevated in the serum. However, the results of immunohistochemical studies demonstrated that DNA-binding monoclonal antibodies bound ex vivo to glomeruli within kidneys prepared from mice at late stages of infection, after the initial damage had been incurred. Our findings suggest how DNA-binding antibodies could contribute to the kidney pathology associated with both malaria and certain autoimmune diseases, such as systemic lupus erythematosus.
我们进行了一系列研究,以检查小鼠疟疾感染期间肾炎的连续发展情况,并确定DNA结合抗体在相关病理过程中的作用。在急性和慢性疟疾感染过程中,对这些抗体的血清水平进行了评估。在感染中期,最初在感染文氏疟原虫或约氏疟原虫尼日利亚株的小鼠中检测到双链DNA和单链DNA结合抗体水平升高,这些水平一直维持到死亡。感染更具慢性的伯氏疟原虫克隆RC也导致单链DNA结合抗体滴度升高,其滴度随感染进展而波动。通过形态学、血尿素氮和排泄白蛋白的变化评估,所有这三种疟原虫都导致了肾脏损伤和功能障碍;这种损伤与寄生虫血症的程度相关,并且在血清中可检测到的DNA结合抗体水平升高之前就已观察到。然而,免疫组织化学研究结果表明,在感染后期从小鼠制备的肾脏中,DNA结合单克隆抗体在体外与肾小球结合,此时已经发生了初始损伤。我们的研究结果表明了DNA结合抗体如何导致与疟疾和某些自身免疫性疾病(如系统性红斑狼疮)相关的肾脏病理变化。